Status:
COMPLETED
Imaging of Vitreous Opacities in a Canadian Population
Lead Sponsor:
PulseMedica
Conditions:
Floaters
Vitreous Opacities
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- Symptomatic vitreous opacities (floaters) in vision
- Clear ocular media, to allow a clear view of the vitreous for the SVO-ID
Exclusion
- Younger than 18 years of age
- Presence of vitreous hemorrhage
- Cataract Grade 3 and above
- Opacification of lens, cornea, or vitreous
- Diagnosis of narrow angle glaucoma
- Refractive error is outside the range of -6D to+3D
- Astigmatism is outside the range of +/-2D of cylinder
Key Trial Info
Start Date :
November 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06204848
Start Date
November 12 2024
End Date
July 31 2025
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alberta Retina Consultants
Edmonton, Alberta, Canada, T5H 0X5